Literature DB >> 15066663

Cell transfection with polycationic cyclodextrin vectors.

Sally-Ann Cryan1, Ann Holohan, Ruth Donohue, Raphael Darcy, Caitriona M O'Driscoll.   

Abstract

Polycationic cyclodextrins (CDs) were complexed with plasmid DNA and their effectiveness as vectors was tested on COS-7 cells. These CDs were modified with pyridylamino, alkylimidazole, methoxyethylamino or primary amine groups at 6-positions of the glucose units. Uncharged CDs, beta-CD, hydroxypropyl-beta-CD, and dimethyl-beta-CD were also tested, but these did not form stable complexes with the DNA and produced only a slight improvement in transfection level over DNA alone. The polycationic CDs neutralised DNA to form stable nanoparticulate complexes. The transfection efficiency of these CDs was dependent on the substituents present, with the most efficient having either an amino, pyridylamino or butylimidazole group at the 6-positions and unmodified 2- and 3-hydroxyls. One of the most effective vectors, heptakispyridylamino CD, produced a 4000-fold increase in transfection level over DNA alone. Levels were improved 10-fold by use of the endosomolytic agent, chloroquine. The transfection efficiency of the best of these systems in serum equals that of DOTAP in serum. Studies with (32)P-labelled plasmid DNA indicate that the polycationic CDs are exceptional promoters of DNA cellular-uptake, the most efficient surpassing DOTAP. Uptake is dependent on proteoglycan-mediated binding to cells. The data imply that intracellular trafficking but not cellular uptake, may be the rate-limiting step in the transfection process. These initial results indicate that CDs are useful templates for further modification to produce molecular constructs capable of enhanced gene delivery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15066663     DOI: 10.1016/j.ejps.2004.01.001

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  19 in total

1.  Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes.

Authors:  Amit A Kale; Vladimir P Torchilin
Journal:  J Drug Target       Date:  2007 Aug-Sep       Impact factor: 5.121

Review 2.  Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.

Authors:  Joel C Sunshine; Corey J Bishop; Jordan J Green
Journal:  Ther Deliv       Date:  2011-04

3.  Evaluation of Chitosan-Tripolyphosphate Nanoparticles as a p-shRNA Delivery Vector: Formulation, Optimization and Cellular Uptake Study.

Authors:  Mahdi Karimi; Pinar Avci; Mohsen Ahi; Tarane Gazori; Michael R Hamblin; Hossein Naderi-Manesh
Journal:  J Nanopharm Drug Deliv       Date:  2013-09-01

4.  Miniaturization of gene transfection assays in 384- and 1536-well microplates.

Authors:  Jing Li; Samuel T Crowley; Jason Duskey; Sanjib Khargharia; Meng Wu; Kevin G Rice
Journal:  Anal Biochem       Date:  2014-10-14       Impact factor: 3.365

5.  Smart DNA vectors based on cyclodextrin polymers: compaction and endosomal release.

Authors:  Véronique Wintgens; Christian Leborgne; Sonia Baconnais; Virginie Burckbuchler; Eric Le Cam; Daniel Scherman; Antoine Kichler; Catherine Amiel
Journal:  Pharm Res       Date:  2011-08-17       Impact factor: 4.200

Review 6.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

7.  Click-modified cyclodextrins as nonviral vectors for neuronal siRNA delivery.

Authors:  A M O'Mahony; B M D C Godinho; J Ogier; M Devocelle; R Darcy; J F Cryan; C M O'Driscoll
Journal:  ACS Chem Neurosci       Date:  2012-08-03       Impact factor: 4.418

8.  Very long chain N4, N9 -diacyl spermines: non-viral lipopolyamine vectors for efficient plasmid DNA and siRNA delivery.

Authors:  Hassan M Ghonaim; Shi Li; Ian S Blagbrough
Journal:  Pharm Res       Date:  2008-09-10       Impact factor: 4.200

Review 9.  Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective.

Authors:  Jianxiang Zhang; Peter X Ma
Journal:  Adv Drug Deliv Rev       Date:  2013-05-11       Impact factor: 15.470

10.  The novel albumin-chitosan core-shell nanoparticles for gene delivery: preparation, optimization and cell uptake investigation.

Authors:  Mahdi Karimi; Pinar Avci; Rezvan Mobasseri; Michael R Hamblin; Hossein Naderi-Manesh
Journal:  J Nanopart Res       Date:  2013-04-01       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.